Skip to main content
OpenTrials

Clinical trial condition

Acute Lymphoblastic Leukemia (ALL)

Explore clinical trials studying Acute Lymphoblastic Leukemia (ALL). Study availability and eligibility vary by location and protocol.

41 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Acute Lymphoblastic Leukemia (ALL) trial results

Completed

Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

NCT02303821

Conditions
Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • University of California San Francisco Benioff Childrens Hospital Oakland Oakland, California, United States
  • Childrens Hospital of Orange County Orange, California, United States
  • Childrens Hospital Colorado Aurora, Colorado, United States
  • Childrens Healthcare of Atlanta, Egleston Atlanta, Georgia, United States
View all 122 locations
View Trial Details
Completed

International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010

NCT01802814

Conditions
Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Australian & New Zealand Childhood Hematology & Oncology Group Clayton, Victoria, Australia
  • St. Anna Kinderkrebsforschung, CCRI Vienna, Austria
  • Hòpital Universitaire des Enfants Reine Fabiola Brussels, Belgium
  • University Hospital Motol Prague, Czechia
View all 17 locations
View Trial Details
Completed

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

NCT01735955

Conditions
Acute Lymphoblastic Leukemia (ALL), Albinism, Amino Acid Metabolism, Inborn Errors, +41 more
Locations
  • Novartis Investigative Site Albany, New York, United States
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Vancouver, British Columbia, Canada
View all 33 locations
View Trial Details
Completed

A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

NCT03236857

Conditions
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Disease Attributes, +28 more
Locations
  • Univ California, San Francisco /ID# 163460 San Francisco, California, United States
  • Children's Hospital Colorado /ID# 161551 Aurora, Colorado, United States
  • Children's Healthcare of Atlan /ID# 161552 Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute /ID# 163440 Boston, Massachusetts, United States
View all 31 locations
View Trial Details
Completed

A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic Lymphoma

NCT03181126

Conditions
Acute Lymphoblastic Leukemia (ALL), Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • City of Hope /ID# 169029 Duarte, California, United States
  • LPCH Stanford /ID# 163337 Palo Alto, California, United States
  • University of Chicago /ID# 163369 Chicago, Illinois, United States
  • Washington University-School of Medicine /ID# 165689 St Louis, Missouri, United States
View all 15 locations
View Trial Details

Related conditions